Connor, Clark & Lunn Investment Management Ltd. Adaptive Biotechnologies Corp Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$18.8 Billion
Q3 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $1.13 Million - $1.68 Million	-179,896 Reduced 66.87%	89,119 $680,000
Q3 2022 Nov 10, 2022	BUY	$6.5 - $12.67 $876,265 - $1.71 Million	134,810 Added 100.45%	269,015 $1.92 Million
Q2 2022 Aug 05, 2022	BUY	$6.4 - $14.73 $723,116 - $1.66 Million	112,987 Added 532.51%	134,205 $1.09 Million
Q1 2022 May 12, 2022	BUY	$10.12 - $28.9 $32,464 - $92,711	3,208 Added 17.81%	21,218 $295,000
Q4 2021 Feb 10, 2022	SELL	$25.17 - $36.85 $140,045 - $205,033	-5,564 Reduced 23.6%	18,010 $505,000
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $707,691 - $939,895	23,574 New	23,574 $801,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$178 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$85.5 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$69.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$68.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$63.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account